(19)
(11) EP 2 318 033 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
27.02.2019 Bulletin 2019/09

(45) Mention of the grant of the patent:
17.10.2018 Bulletin 2018/42

(21) Application number: 09777419.4

(22) Date of filing: 24.07.2009
(51) International Patent Classification (IPC): 
A61K 38/17(2006.01)
 A61P 29/00(2006.01)
(86) International application number:
PCT/EP2009/005381
(87) International publication number:
WO 2010/009892 (28.01.2010 Gazette 2010/04)

(54)

COMPOSITIONS FOR THE TREATMENT OF PAIN AND/OR INFLAMMATION

ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON SCHMERZEN UND/ODER ENTZÜNDUNGEN

COMPOSITIONS DESTINÉES AU TRAITEMENT DE LA DOULEUR ET/OU DE L'INFLAMMATION

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 24.07.2008 ES 200802210

(43) Date of publication of application:
11.05.2011 Bulletin 2011/19

(73) Proprietor: BCN Peptides, S.A.
08777 Sant Quintí de Mediona (ES)

(72) Inventors:
  • CARRENO SERRAÏMA, Cristina
    08015 Barcelona (ES)
  • VAN DEN NEST, Wim
    08800 Vilanova I La Geltrú - Barcelona (ES)
  • FERRER MONTIEL, Antonio
    03540 Playa de San Juan-Alicante (ES)
  • CAMPRUBÍ ROBLES, Maria
    03540 Playa de San Juan-Alicante (ES)
  • FERNÁNDEZ CARNEADO, Jimena
    33300 Villaviciosa (Asturias) (ES)
  • PONSATI OBIOLS, Berta
    08005 Barcelona (ES)

(74) Representative: Carvajal y Urquijo, Isabel et al
Clarke, Modet & Co. Suero de Quiñones, 34-36
28002 Madrid
28002 Madrid (ES)


(56) References cited: : 
WO-A1-97/34620
WO-A2-01/78760
 WO-A1-02/089834
WO-A2-2007/093807
   
  • DATABASE WPI Week 200951 Thomson Scientific, London, GB; AN 2009-J28980 XP002573254 & KR 2009 041 066 A (UNIV SUNGKYUNKWAN FOUND CORP COLLABORATI) 28 April 2009 (2009-04-28)
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).